Recent evidence has suggested that many children with autism have low levels of glutathione in their cells.

The scientific community wanted to put this discovery to the test by boosting intracellular glutathione levels in children to see how this affected autism.

To increase glutathione levels intracellularly they of course turned to Immunocal (HMS 90 in Canada) and conducted a 6?week open-label clinical trial on the use of Immunocal® on children with autism.

The specific questions addressed during this study were:

1. Will the children take the supplement?
2. Will the supplement be tolerated?
3. What behavioral changes were documented?

from Immunotec on 8/29/08:

“We’re proud to announce that the results were promising and will allow for further studies to proceed in order to fully demonstrate the benefits of augmented glutathione levels in children with autism.”

This is indeed great news. Immunocal is one of the very few patented neutraceuticals and, as such, is already being accepted by mainstream medical practicioners and naturalists alike

clinical trials like this one only add to the compelling evidence that increasing glutathione is tremendously beneficial for many troubling disease states and that Immunocal is the safest, most natural way to boost intracellular glutathione levels (outside of drinking 4 gallons of raw organic milk everyday :) ).

We look forward to the follow up results.